122 related articles for article (PubMed ID: 26976104)
21. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder.
Hooper CL; Bakish D
J Psychiatry Neurosci; 2000 Mar; 25(2):178-84. PubMed ID: 10740991
[TBL] [Abstract][Full Text] [Related]
22. Clinical effect of nemifitide, a novel pentapeptide antidepressant, in the treatment of severely depressed refractory patients.
Feighner JP; Sverdlov L; Hlavka J; Nicolau G; Cartwright K; Freed JS
Int Clin Psychopharmacol; 2008 Jan; 23(1):29-35. PubMed ID: 18090505
[TBL] [Abstract][Full Text] [Related]
23. [Structured interview guide for evaluating depression in elderly patients, adapted from DSM IV and the GDS, HDRS and MADRS scales].
Tison P
Encephale; 2000; 26(3):33-43. PubMed ID: 10951904
[TBL] [Abstract][Full Text] [Related]
24. Reliability and validity of the Thai version of the Calgary Depression Scale for Schizophrenia.
Suttajit S; Srisurapanont M; Pilakanta S; Charnsil C; Suttajit S
Neuropsychiatr Dis Treat; 2013; 9():113-8. PubMed ID: 23355781
[TBL] [Abstract][Full Text] [Related]
25. Web-based assessment of depression in patients treated in clinical practice: reliability, validity, and patient acceptance.
Zimmerman M; Martinez JH
J Clin Psychiatry; 2012 Mar; 73(3):333-8. PubMed ID: 22154899
[TBL] [Abstract][Full Text] [Related]
26. Clinical validation of the Psychotic Depression Assessment Scale (PDAS) against independent global severity ratings in older adults.
Vermeulen T; Lemey L; Van Diermen L; Schrijvers D; Madani Y; Sabbe B; Van Den Bossche MJA; van der Mast RC; Østergaard SD
Acta Neuropsychiatr; 2018 Aug; 30(4):203-208. PubMed ID: 29501075
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
28. [Validation of the Montgomery-Åsberg Depression Rating Scale (MADRS) in Colombia].
Cano JF; Gomez Restrepo C; Rondón M
Rev Colomb Psiquiatr; 2016; 45(3):146-55. PubMed ID: 27569008
[TBL] [Abstract][Full Text] [Related]
29. Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study.
Han C; Wang SM; Kwak KP; Won WY; Lee H; Chang CM; Tang TC; Pae CU
J Psychiatr Res; 2015; 66-67():84-94. PubMed ID: 26013203
[TBL] [Abstract][Full Text] [Related]
30. [Validation of HARD (Hamilton depression rating scale) a diagram of the evaluation of depression by MADRS (Montgomery-Asberg depression rating scale) Multicentric study of mianserin].
Ferreri M; Cousin FR; Rufin JC; Alby JM
Encephale; 1986; 12(6):343-50. PubMed ID: 3545786
[TBL] [Abstract][Full Text] [Related]
31. The Montgomery-Asberg Depression Rating Scale and the Cornell Scale for Depression in Dementia: a validation study with patients exhibiting early-onset dementia.
Leontjevas R; van Hooren S; Mulders A
Am J Geriatr Psychiatry; 2009 Jan; 17(1):56-64. PubMed ID: 19092312
[TBL] [Abstract][Full Text] [Related]
32. Using longitudinal data from a clinical trial in depression to assess the reliability of its outcome scales.
Laenen A; Alonso A; Molenberghs G; Vangeneugden T; Mallinckrodt CH
J Psychiatr Res; 2009 Apr; 43(7):730-8. PubMed ID: 18986657
[TBL] [Abstract][Full Text] [Related]
33. Differentiating moderate and severe depression using the Montgomery-Asberg depression rating scale (MADRS).
Müller MJ; Himmerich H; Kienzle B; Szegedi A
J Affect Disord; 2003 Dec; 77(3):255-60. PubMed ID: 14612225
[TBL] [Abstract][Full Text] [Related]
34. Social anxiety symptoms across diagnoses among outpatients attending a tertiary care mood and anxiety disorders service.
Graystone HJ; Garner MJ; Baldwin DS
J Affect Disord; 2009 Apr; 114(1-3):305-9. PubMed ID: 18656267
[TBL] [Abstract][Full Text] [Related]
35. Optimizing the ability of the Hamilton Depression Rating Scale to discriminate across levels of severity and between antidepressants and placebos.
Santor DA; Debrota D; Engelhardt N; Gelwicks S
Depress Anxiety; 2008; 25(9):774-86. PubMed ID: 17935212
[TBL] [Abstract][Full Text] [Related]
36. Screening for anxiety and depression after stroke: comparison of the hospital anxiety and depression scale and the Montgomery and Asberg depression rating scale.
Sagen U; Vik TG; Moum T; Mørland T; Finset A; Dammen T
J Psychosom Res; 2009 Oct; 67(4):325-32. PubMed ID: 19773025
[TBL] [Abstract][Full Text] [Related]
37. Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice.
Bondolfi G; Jermann F; Rouget BW; Gex-Fabry M; McQuillan A; Dupont-Willemin A; Aubry JM; Nguyen C
J Affect Disord; 2010 Mar; 121(3):268-72. PubMed ID: 19660815
[TBL] [Abstract][Full Text] [Related]
38. Relationship between the Hamilton Depression Rating Scale and the Montgomery-Asberg Depression Rating Scale in depressed elderly: a meta-analysis.
Heo M; Murphy CF; Meyers BS
Am J Geriatr Psychiatry; 2007 Oct; 15(10):899-905. PubMed ID: 17911366
[TBL] [Abstract][Full Text] [Related]
39. [Application of a structured interview guide adapted to 4 depression scales].
Fleck MP; Guelfi JD; Poirier-Littré MF; Lôo H
Encephale; 1994; 20(5):479-86. PubMed ID: 7828510
[TBL] [Abstract][Full Text] [Related]
40. [Studies of the reliability and validity of the German version of the Montgomery-Asberg Depression Rating Scale (MADRS)].
Schmidtke A; Fleckenstein P; Moises W; Beckmann H
Schweiz Arch Neurol Psychiatr (1985); 1988; 139(2):51-65. PubMed ID: 2455937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
